People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate,…
A Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal antibody therapy for its safety and efficacy in people who have mild…
Review of the life histories of RNA viruses, their genetics, and the compounds that could disrupt them offers hope for curtailment of future pandemics. Researchers…
Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness. In an in-depth study of how COVID-19…
A self-administered ‘scratch-and-sniff’ test for COVID-19 may be around the corner, according to researchers at Penn State, the University of Florida, and Arizona State University….
Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections. National Institutes of Health researchers have isolated a set of promising, tiny…
The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results…
Diagnosing liver damage earlier could help to prevent liver failure in many patients. About 25 percent of the U.S. population suffers from fatty liver disease,…
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, announced that the fourth iteration of the Adaptive COVID-19…
Funding from the National Institutes of Health will enable a Penn State researcher to study whether vitamin D supplementation could help people ward off or…
The protein, which acts as an ion channel, could be a target for new drugs against the SARS-CoV-2 virus. MIT chemists have determined the molecular…
A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has…
Mice treated with apigenin had better memory and developmental milestone scores. The plant compound apigenin improved the cognitive and memory deficits usually seen in a…
Scientists use gene therapy and a novel light-sensing protein to restore vision in mice. NIH-funded therapy will now be tested in humans. A newly developed…
In a National Institutes of Health-funded study involving both mice and patients who are part of an NIH Clinical Center trial, researchers discovered that a…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, launched a study on October 13, 2020, designed to…
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir…
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in…
